JIM CRAMERStarbucks, Square, Alibaba: 'Mad Money' Lightning RoundBy Scott RuttJan 14, 2019 9:15 PM EST
PRESS RELEASESDynavax Announces Collaboration With The University Of Queensland And The Coalition For Epidemic Preparedness (CEPI) Focused On The Development Of A Coronavirus (COVID-19) VaccineBy GlobeNewswireMar 2, 2020 8:00 AM EST
PRESS RELEASESDynavax To Present At The Cowen 40th Annual Health Care ConferenceBy GlobeNewswireFeb 18, 2020 4:05 PM EST
PRESS RELEASESDynavax Announces Partnership With Albertsons Companies' Pharmacies To Offer HEPLISAV-B® Hepatitis B Vaccine To Patients NationwideBy GlobeNewswireDec 5, 2019 8:00 AM EST
PRESS RELEASESDynavax Announces HEPLISAV-B Post-Marketing Requirement Interim Report CompletedBy GlobeNewswireDec 3, 2019 2:00 AM EST
JIM CRAMERStarbucks, Square, Alibaba: 'Mad Money' Lightning RoundBy Scott RuttJan 14, 2019 9:15 PM EST
JIM CRAMERBreaking Down Citigroup Earnings: Cramer's 'Mad Money' RecapBy Scott RuttJan 14, 2019 8:59 PM EST
JIM CRAMERChildren's Place, Abiomed, Barrick Gold: 'Mad Money' Lightning RoundBy Scott RuttJul 17, 2018 6:36 AM EDT
JIM CRAMERBe Alert For Buying Opportunities: Cramer's 'Mad Money' RecapBy Scott RuttJul 17, 2018 6:27 AM EDT
JIM CRAMERTwilio, Apache, Tellurian: 'Mad Money' Lightning RoundBy Scott RuttMar 10, 2018 7:41 AM EST
JIM CRAMERResist All the Dow 22K Hoopla: Cramer's 'Mad Money' RecapBy Scott RuttAug 3, 2017 6:41 AM EDT
JIM CRAMERChevron, Universal Display, Dynavax Technologies, Schlumberger: 'Mad Money' Lightning RoundBy Scott RuttAug 3, 2017 6:34 AM EDT
FUTURESDow's Big Day Ends With Record and Best Monthly Gain Since FebruaryBy Keris Alison LahiffJul 31, 2017 4:17 PM EDT
FUTURESDow on Track for Records as Boeing Gains, Nasdaq DropsBy Keris Alison LahiffJul 31, 2017 2:21 PM EDT
FUTURESDow at Records, Rest of Market Retreats, in Close to Strong JulyBy Keris Alison LahiffJul 31, 2017 11:08 AM EDT
FUTURESThe Stock Market Looks Like It Could End July With a BangBy Keris Alison LahiffJul 31, 2017 8:41 AM EDT
VIDEOCould These 9 Drugs Gain FDA Approval in the Age of Trump?By TheStreet StaffMar 8, 2017 12:40 PM EST
STOCKSWhat Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016By Adam FeuersteinDec 22, 2016 11:20 AM EST
STOCKS5 stocks poised for major breakouts: gold, pharma, techBy Roberto PedoneDec 4, 2016 4:40 PM EST
FUTURESDow scores slim new record while nasdaq, s&p 500 fallBy Keris Alison LahiffNov 14, 2016 4:06 PM EST
